Bitopertin
- Generic Name
- Bitopertin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C21H20F7N3O4S
- CAS Number
- 845614-11-1
- Unique Ingredient Identifier
- Q8L6AN59YY
- Background
Bitopertin has been used in trials studying the treatment of Schizophrenia and Obsessive-Compulsive Disorder.
- Associated Conditions
- -
- Associated Therapies
- -
Study of the Selective GlyT1 Inhibitor Bitopertin for Steroid-Refractory Diamond-Blackfan Anemia
- Conditions
- Interventions
- First Posted Date
- 2023-04-25
- Last Posted Date
- 2024-04-10
- Target Recruit Count
- 30
- Registration Number
- NCT05828108
- Locations
- ๐บ๐ธ
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
A Study of Bitopertin (RO4917838) in Adults With Non-Transfusion-Dependent (NTD) Beta-Thalassemia
- First Posted Date
- 2017-09-05
- Last Posted Date
- 2018-10-05
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 12
- Registration Number
- NCT03271541
- Locations
- ๐ฎ๐น
Ospedale Maggiore di Milano; Cardio-Metabolic Diseases, Milano, Lombardia, Italy
๐น๐ญSiriraj Hospital; Division of Haematology-Oncology, Bangkok Noi, Thailand
๐ฑ๐งChronic Care Center, Baabda, Lebanon
A Study Exmining the Effect of Multiple Doses of Bitopertin on the Single Dose Pharmacokinetics of Midazolam in Healthy Volunteers.
- First Posted Date
- 2013-12-24
- Last Posted Date
- 2017-10-25
- Lead Sponsor
- Hoffmann-La Roche
- Registration Number
- NCT02019290
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors (SSRIs) in Participants With Obsessive-Compulsive Disorder (OCD)
- Conditions
- Interventions
- First Posted Date
- 2012-08-28
- Last Posted Date
- 2017-08-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 99
- Registration Number
- NCT01674361
- Locations
- ๐บ๐ธ
Keystone Clinical Studies, LLC, Norristown, Pennsylvania, United States
๐บ๐ธCompass Research North, LLC, Leesburg, Florida, United States
๐จ๐ฆMcMaster University - MacAnxiety Research Centre, Hamilton, Ontario, Canada
A Study of Bitopertin (RO4917838) in Healthy Male Volunteers
- First Posted Date
- 2012-07-10
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 71
- Registration Number
- NCT01636492
A Study to Evaluate Efficacy and Safety of Bitopertin in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia
- Conditions
- Interventions
- First Posted Date
- 2010-09-01
- Last Posted Date
- 2017-02-15
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 625
- Registration Number
- NCT01192880
- Locations
- ๐บ๐ธ
Synergy Clinical Research of Escondido, Escondido, California, United States
๐บ๐ธExcell Research, Oceanside, California, United States
๐บ๐ธBehavioral Clinical Research Inc., Lauderhill, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.